Abstract
The management of patients with breast cancer has been changing over the last few years and this article highlights some areas of particular interest. The changes have been brought about against a background of an increasing disease incidence coupled with increasing political aspirations from patients and their relatives. This paper focuses on organisational aspects of breast cancer care, screening, induction and high-dose chemotherapy, clinical trials, genetics, training of surgical and nonsurgical oncologists and future prospects.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bronchud M. H., Howell A., Crowther D., Hopwood P., Souza L., Dexter T. M. The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. Br J Cancer. 1989 Jul;60(1):121–125. doi: 10.1038/bjc.1989.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ford D., Easton D. F., Bishop D. T., Narod S. A., Goldgar D. E. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet. 1994 Mar 19;343(8899):692–695. doi: 10.1016/s0140-6736(94)91578-4. [DOI] [PubMed] [Google Scholar]
- Lewis W. G., Walker V. A., Ali H. H., Sainsbury J. R. Intra-arterial chemotherapy in patients with breast cancer: a feasibility study. Br J Cancer. 1995 Mar;71(3):605–609. doi: 10.1038/bjc.1995.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sainsbury R., Haward B., Rider L., Johnston C., Round C. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet. 1995 May 20;345(8960):1265–1270. doi: 10.1016/s0140-6736(95)90924-9. [DOI] [PubMed] [Google Scholar]
- Sainsbury R. Intra-arterial chemotherapy for breast cancer. Br J Surg. 1991 Jul;78(7):769–770. doi: 10.1002/bjs.1800780702. [DOI] [PubMed] [Google Scholar]
- Sainsbury R., Rider L., Smith A., MacAdam A. Does it matter where you live? Treatment variation for breast cancer in Yorkshire. The Yorkshire Breast Cancer Group. Br J Cancer. 1995 Jun;71(6):1275–1278. doi: 10.1038/bjc.1995.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith I. E., Walsh G., Jones A., Prendiville J., Johnston S., Gusterson B., Ramage F., Robertshaw H., Sacks N., Ebbs S. High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer. J Clin Oncol. 1995 Feb;13(2):424–429. doi: 10.1200/JCO.1995.13.2.424. [DOI] [PubMed] [Google Scholar]
- Wald N. J., Murphy P., Major P., Parkes C., Townsend J., Frost C. UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening. BMJ. 1995 Nov 4;311(7014):1189–1193. doi: 10.1136/bmj.311.7014.1189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wood W. C., Budman D. R., Korzun A. H., Cooper M. R., Younger J., Hart R. D., Moore A., Ellerton J. A., Norton L., Ferree C. R. Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. N Engl J Med. 1994 May 5;330(18):1253–1259. doi: 10.1056/NEJM199405053301801. [DOI] [PubMed] [Google Scholar]
- Woodman C. B., Threlfall A. G., Boggis C. R., Prior P. Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. BMJ. 1995 Jan 28;310(6974):224–226. doi: 10.1136/bmj.310.6974.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wright C. J., Mueller C. B. Screening mammography and public health policy: the need for perspective. Lancet. 1995 Jul 1;346(8966):29–32. doi: 10.1016/s0140-6736(95)92655-0. [DOI] [PubMed] [Google Scholar]